HALO - Roche's Ocrevus SC administration approved by European Commission
2024-06-25 06:36:05 ET
More on Halozyme Therapeutics
- Halozyme Therapeutics: The Story Brightens
- Halozyme Therapeutics, Inc. (HALO) Q1 2024 Earnings Call Transcript
- Halozyme Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Bristol Myers Opdivo injectable accepted for EU review
- Halozyme downgraded at Piper Sandler despite guidance raise